This new article publication from Acta Pharmaceutica Sinica B, discusses how key imidazolyl groups that induce phenylalanine flipping enhance the efficacy of oral BRD9 inhibitors for AML treatment.
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback